Truist Financial Reaffirms Their Buy Rating on Genmab (GMAB) - The Globe and Mail

Retrieved on: 2025-10-01 13:41:21

Tags for this article:

Click the tags to see associated articles and topics

Truist Financial Reaffirms Their Buy Rating on Genmab (GMAB) - The Globe and Mail. View article details on hiswai:

Excerpt

Goonewardene covers the Healthcare sector, focusing on stocks such as Summit Therapeutics, Genmab, and BioNTech SE. In addition to Truist ...

Article found on: www.theglobeandmail.com